QT dynamicity, influence of the autonomic nervous system and the risk of major arrhythmic events in idiopathic dilated cardiomyopathy

被引：0

作者：

Fauchier, L ^{[1
]}

Babuty, D ^{[1
]}

Poret, P ^{[1
]}

Autret, ML ^{[1
]}

Tena-Carbi, D ^{[1
]}

Cosnay, P ^{[1
]}

Fauchier, JP ^{[1
]}

机构：

[1] Trousseau Univ Hosp, Cardiol Dept B, Tours, France

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2000年 / 35卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：121A / 121A

页数：1

共 50 条

[21] THE INFLUENCE OF THE AUTONOMIC NERVOUS-SYSTEM ON QT INTERVAL [J].

BROWNE, KF ;

ZIPES, DP ;

HEGER, JJ ;

PRYSTOWSKY, EN .

AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (04) :898-898

[22] Arg16Arg genotype of the beta2-adrenergic receptor predicts lower risk for major arrhythmic events in patients with idiopathic dilated cardiomyopathy [J].

Forleo, C ;

Guida, R ;

Sorrentino, S ;

Iacoviello, M ;

Romito, R ;

Massari, F ;

Pitzalis, MV ;

Rizzon, P .

EUROPEAN HEART JOURNAL, 2004, 25 :6-6

[23] Different criteria of cardiac resynchronization therapy and their prognostic value for worsening heart failure or major arrhythmic events in patients with idiopathic dilated cardiomyopathy [J].

Fauchier, L ;

Poret, P ;

Robin, I ;

de Labriolle, A ;

Giraudeau, C ;

Cosnay, P ;

Babuty, D .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (03) :393-399

[24] Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy and No Conventional Indications for Implantable Cardiac Defibrillator [J].

Merlo, Marco ;

Pirozzi, Fabrizio ;

Stolfo, Davide ;

Gianluca, D'Angelo ;

Alonge, Marco ;

Gigli, Marta ;

Barbati, Giulia ;

Zecchin, Massimo ;

Sinagra, Gianfranco .

CIRCULATION, 2014, 130

[25] The Role of n-3 PUFAs in Preventing the Arrhythmic Risk in Patients with Idiopathic Dilated Cardiomyopathy [J].

Savina Nodari ;

Marco Metra ;

Giuseppe Milesi ;

Alessandra Manerba ;

Bruno Mario Cesana ;

Mihai Gheorghiade ;

Livio Dei Cas .

Cardiovascular Drugs and Therapy, 2009, 23 :5-15

[26] The Role of n-3 PUFAs in Preventing the Arrhythmic Risk in Patients with Idiopathic Dilated Cardiomyopathy [J].

Nodari, Savina ;

Metra, Marco ;

Milesi, Giuseppe ;

Manerba, Alessandra ;

Cesana, Bruno Mario ;

Gheorghiade, Mihai ;

Dei Cas, Livio .

CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) :5-15

[27] Different criteria of cardiac resynchronization therapy have different prognostic value for worsening heart failure or major arrhythmic events in idiopathic dilated cardiomyopathy [J].

Fauchier, L ;

Douglas, J ;

Babuty, D ;

Marie, O ;

Cosnay, P ;

Bonnet, P ;

Fauchier, JP .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :210A-210A

[28] Deep learning-based prediction of major arrhythmic events in dilated cardiomyopathy: A proof of concept study [J].

Coriano, Mattia ;

Lanera, Corrado ;

De Michieli, Laura ;

Perazzolo Marra, Martina ;

Iliceto, Sabino ;

Gregori, Dario ;

Tona, Francesco .

PLOS ONE, 2024, 19 (02)

[29] Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy [J].

Osa, A ;

Almenar, L ;

Palencia, M ;

Puig, N ;

Chirivella, M ;

Montoro, J .

CLINICAL CARDIOLOGY, 1999, 22 (04) :292-296

[30] A high-risk late gadolinium enhancement pattern is associated with arrhythmic events in patients with dilated cardiomyopathy [J].

Zulet Fraile, P. ;

Ferrandez Escarabajal, M. ;

Islas, F. ;

Travieso Gonzalez, A. ;

Restrepo, A. ;

Goirigolzarri, J. A. ;

De Agustin Loeches, A. ;

Vilacosta, I. ;

Olmos Blanco, C. .

EUROPEAN HEART JOURNAL, 2023, 44

← 1 2 3 4 5 →